30227591|t|Isolation of Novel Sesquiterpeniods and Anti-neuroinflammatory Metabolites from Nardostachys jatamansi.
30227591|a|Nardostachys jatamansi contains various types of sesquiterpenoids that may play an important role in the potency of plant's anti-inflammatory effects, depending on their structure. In this study, five new sesquiterpenoids, namely kanshone L (1), kanshone M (2), 7-methoxydesoxo-narchinol (3), kanshone N (4), and nardosdaucanol (5), were isolated along with four known terpenoids (kanshone D (6), nardosinanone G (7), narchinol A (8), and nardoaristolone B (9)) from the rhizomes and roots of Nardostachys jatamansi. Their structures were determined by analyzing 1D and 2D NMR and MS data. Among the nine sesquiterpenoids, compounds 3, 4, and 8 were shown to possess dose-dependent inhibitory effects against lipopolysaccharide (LPS)-stimulated nitric oxide (NO) production in BV2 microglial cells. Furthermore, compounds 3, 4, and 8 exhibited anti-neuroinflammatory effects by inhibiting the production of pro-inflammatory mediators, including prostaglandin E2 (PGE2), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) proteins, as well as pro-inflammatory cytokines, such as interleukin (IL)-1beta, IL-12 and tumor necrosis factor-alpha (TNF-alpha), in LPS-stimulated BV2 microglial cells. Moreover, these compounds were shown to inhibit the activation of the NF-kappaB signaling pathway in LPS-stimulated BV2 microglial cells by suppressing the phosphorylation of IkappaB-alpha and blocking NF-kappaB translocation. In conclusion, five new and four known sesquiterpenoids were isolated from Nardostachys jatamansi, and compounds 3, 4, and 8 exhibited anti-neuroinflammatory effects in LPS-stimulated BV2 microglial cells through inhibiting of NF-kappaB signaling pathway.
30227591	19	35	Sesquiterpeniods	Chemical	-
30227591	45	62	neuroinflammatory	Disease	MESH:D000090862
30227591	80	102	Nardostachys jatamansi	Species	
30227591	104	126	Nardostachys jatamansi	Species	
30227591	153	169	sesquiterpenoids	Chemical	MESH:D012717
30227591	233	245	inflammatory	Disease	MESH:D007249
30227591	309	325	sesquiterpenoids	Chemical	MESH:D012717
30227591	334	344	kanshone L	Chemical	-
30227591	350	360	kanshone M	Chemical	-
30227591	366	391	7-methoxydesoxo-narchinol	Chemical	-
30227591	397	407	kanshone N	Chemical	-
30227591	417	431	nardosdaucanol	Chemical	-
30227591	473	483	terpenoids	Chemical	MESH:D013729
30227591	485	495	kanshone D	Chemical	-
30227591	501	516	nardosinanone G	Chemical	-
30227591	522	533	narchinol A	Chemical	-
30227591	543	560	nardoaristolone B	Chemical	MESH:C581893
30227591	597	619	Nardostachys jatamansi	Species	
30227591	709	725	sesquiterpenoids	Chemical	MESH:D012717
30227591	727	748	compounds 3, 4, and 8	Chemical	-
30227591	813	831	lipopolysaccharide	Chemical	MESH:D008070
30227591	833	836	LPS	Chemical	MESH:D008070
30227591	849	861	nitric oxide	Chemical	MESH:D009569
30227591	881	884	BV2	CellLine	CVCL:0182
30227591	916	937	compounds 3, 4, and 8	Chemical	-
30227591	953	970	neuroinflammatory	Disease	MESH:D000090862
30227591	1015	1027	inflammatory	Disease	MESH:D007249
30227591	1049	1065	prostaglandin E2	Chemical	MESH:D015232
30227591	1067	1071	PGE2	Chemical	MESH:D015232
30227591	1074	1105	inducible nitric oxide synthase	Gene	18126
30227591	1107	1111	iNOS	Gene	18126
30227591	1118	1134	cyclooxygenase-2	Gene	19225
30227591	1136	1141	COX-2	Gene	19225
30227591	1168	1180	inflammatory	Disease	MESH:D007249
30227591	1200	1222	interleukin (IL)-1beta	Gene	16176
30227591	1234	1261	tumor necrosis factor-alpha	Gene	21926
30227591	1263	1272	TNF-alpha	Gene	21926
30227591	1278	1281	LPS	Chemical	MESH:D008070
30227591	1293	1296	BV2	CellLine	CVCL:0182
30227591	1385	1394	NF-kappaB	Gene	18033
30227591	1416	1419	LPS	Chemical	MESH:D008070
30227591	1431	1434	BV2	CellLine	CVCL:0182
30227591	1490	1503	IkappaB-alpha	Gene	18035
30227591	1517	1526	NF-kappaB	Gene	18033
30227591	1581	1597	sesquiterpenoids	Chemical	MESH:D012717
30227591	1617	1639	Nardostachys jatamansi	Species	
30227591	1645	1666	compounds 3, 4, and 8	Chemical	-
30227591	1682	1699	neuroinflammatory	Disease	MESH:D000090862
30227591	1711	1714	LPS	Chemical	MESH:D008070
30227591	1726	1729	BV2	CellLine	CVCL:0182
30227591	1769	1778	NF-kappaB	Gene	18033
30227591	Negative_Correlation	MESH:D012717	18033
30227591	Association	MESH:D015232	MESH:D007249
30227591	Association	MESH:D007249	19225
30227591	Negative_Correlation	MESH:D015232	MESH:D000090862
30227591	Association	MESH:D007249	16176
30227591	Association	MESH:D008070	16176
30227591	Association	MESH:D007249	21926
30227591	Negative_Correlation	MESH:D009569	MESH:D012717
30227591	Negative_Correlation	MESH:D012717	MESH:D000090862
30227591	Negative_Correlation	MESH:D012717	MESH:D007249
30227591	Association	18033	18035
30227591	Negative_Correlation	MESH:D008070	MESH:D012717
30227591	Positive_Correlation	MESH:D008070	MESH:D009569
30227591	Association	MESH:D000090862	18033
30227591	Association	MESH:D000090862	19225
30227591	Association	MESH:D007249	18126
30227591	Association	MESH:D008070	21926
30227591	Positive_Correlation	MESH:D008070	MESH:D007249
30227591	Association	MESH:D000090862	18126
30227591	Association	MESH:D008070	18033

